The patent on the cancer drug Revlimid (lenalidomide) recently expired. Whereas a few weeks ago a pack still cost over 4,500 euros, after generic competition
Lucien Hordijk (1988) has been covering the pharmaceutical industry for six years, reporting on skyrocketing prices, regulatory capture, generic shortages, biosimilars and industry lobbying. His investigations led to national publications and international coverage in the Financial Times, The Wall Street Journal and Reuters.
By Lucien Hordijk and Daan Marselis Using a set of legal tricks, the pharmaceutical industry was able to turn an animal gallic acid into a
Leaked documents show that the European Commission put pressure on the European Medicines Agency to approve the first Covid-19 vaccines simultaneously with the American FDA.
The drug’s manufacturer was aware of the negative results of the Solidarity trial before the European Commission struck a procurement deal with it, finds an